Repare Therapeutics News - RPTX

Company Name	Stock Ticker Symbol	Market	Type
Repare Therapeutics Inc	RPTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.15	-4.55%	3.15	18:46:45

Open Price	Low Price	High Price	Close Price	Prev Close
3.235	3.1144	3.235	3.15	3.30

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/05/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	21:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	21:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	07:05	BW	Repare Therapeutics to Participate in Two Upcoming Investor..
2/28/2024	16:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/28/2024	07:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/2024	07:10	EDGAR2	Form 8-K - Current report
2/28/2024	07:05	BW	Repare Therapeutics Provides Business Update and Reports..
2/15/2024	07:05	BW	Repare Therapeutics Doses First Patient in Phase 1 Clinical..
2/14/2024	21:02	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	08:54	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	16:48	EDGAR2	Form 8-K - Current report
2/12/2024	16:05	BW	Repare Therapeutics to Regain Global Rights to Camonsertib
1/25/2024	14:29	EDGAR2	Form 8-K - Current report
1/25/2024	07:00	BW	Repare Therapeutics Announces Achievement of $40 Million..
1/12/2024	16:05	EDGAR2	Form 8-K - Current report
1/08/2024	07:00	BW	Repare Therapeutics Provides Corporate Update and Highlights..
1/04/2024	16:05	BW	Repare Therapeutics and Debiopharm Partner to Explore the..
12/29/2023	16:05	BW	Repare Therapeutics Insiders Establish Automatic Securities..
12/12/2023	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/15/2023	07:20	EDGAR2	Form 8-K - Current report
11/15/2023	07:00	BW	Repare Therapeutics Unveils Two Programs Expected to Enter..
11/09/2023	07:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:05	EDGAR2	Form 8-K - Current report
11/09/2023	07:00	BW	Repare Therapeutics Provides Business Update and Reports..
11/07/2023	07:00	BW	Repare Therapeutics to Host Investor and Analyst Conference..
11/06/2023	07:00	BW	Repare Therapeutics to Participate in Two Upcoming Investor..
10/13/2023	17:15	EDGAR2	Form 8-K - Current report
10/13/2023	09:47	EDGAR2	Form 8-K - Current report
10/13/2023	09:40	BW	Repare Therapeutics Announces Positive Initial Data from..
10/06/2023	07:56	EDGAR2	Form 8-K - Current report
10/03/2023	07:00	BW	Repare Therapeutics to Host Conference Call and Webcast to..
9/19/2023	07:00	BW	Repare Therapeutics to Present Preliminary Phase 1 MYTHIC..
9/06/2023	07:00	BW	Repare Therapeutics to Participate at the Morgan Stanley..
8/09/2023	16:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	16:09	EDGAR2	Form 8-K - Current report
8/09/2023	16:05	BW	Repare Therapeutics Provides Business Update and Reports..
6/08/2023	07:00	BW	Repare Therapeutics to Participate at the Goldman Sachs 44th..
6/07/2023	16:05	BW	Repare Therapeutics Reports Proof of Concept for Lunresertib..
6/06/2023	07:00	BW	Repare Therapeutics Announces Publication in Nature Medicine..
6/02/2023	07:00	BW	Repare Therapeutics to Host Conference Call and Webcast to..
5/22/2023	07:00	BW	Repare Reports Inducement Grant Under Nasdaq Listing Rule..
5/09/2023	16:05	BW	Repare Therapeutics Provides Business Update and Reports..
4/28/2023	16:05	BW	Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its..